Federated Hermes, Inc. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-07 11:08 am Purchase | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,635,380 13.150% | 156,733 (+10.60%) | Filing |
| 2025-09-05 09:38 am Purchase | 2025-08-31 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,478,647 11.890% | 406,414 (+37.90%) | Filing |
| 2025-07-08 07:50 am Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | FEDERATED HERMES INC. FHI | 1,072,233 8.780% | 1,072,233 (New Position) | Filing |